Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter de Boer

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Brain Sciences|December 19, 2019
Neuroendocrine and Inflammatory Effects of Childhood Trauma Following Psychosocial and Inflammatory Stress in Women with Remitted Major Depressive DisorderLaura L M Cassiers, Peter Niemegeers, Erik Fransen, et al.
Critical Care Medicine|April 10, 2002
Inhibition of p38 mitogen-activated protein kinase: dose-dependent suppression of leukocyte and endothelial response after endotoxin challenge in humansJan Willem Fijen, Jaap E Tulleken, Anneke C Muller Kobold, et al.
Experimental Brain Research|August 11, 2016
Implicit motor sequence learning in schizophrenia and in old age: reduced performance only in the third sessionClaudia Cornelis, Livia J De Picker, Peter De Boer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 5, 2017
Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy : A comparison of benefitsPeter de Boer, Agustinus J A J van de Schoot, Henrike Westerveld, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2014
Pharmacology of JNJ-42314415, a centrally active phosphodiesterase 10A (PDE10A) inhibitor: a comparison of PDE10A inhibitors with D2 receptor blockers as potential antipsychotic drugsAnton A H P Megens, Herman M R Hendrickx, Koen A Hens, et al.
Translational Psychiatry|September 5, 2019
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorderKasper Recourt, Peter de Boer, Rob Zuiker, et al.
Translational Psychiatry|October 4, 2019
Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorderKasper Recourt, Peter de Boer, Rob Zuiker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Patterns of care survey: Radiotherapy for women with locally advanced cervical cancerPeter de Boer, Ina M Jürgenliemk-Schulz, Henrike Westerveld, et al.
Cell|July 15, 2006
Resolution of chiasmata in oocytes requires separase-mediated proteolysisNobuaki R Kudo, Katja Wassmann, Martin Anger, et al.
European Radiology|June 27, 2018
Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: a multicentre studyMaarten G Thomeer, Vincent Vandecaveye, Loes Braun, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Brain Sciences|December 19, 2019
Neuroendocrine and Inflammatory Effects of Childhood Trauma Following Psychosocial and Inflammatory Stress in Women with Remitted Major Depressive DisorderLaura L M Cassiers, Peter Niemegeers, Erik Fransen, et al.
Critical Care Medicine|April 10, 2002
Inhibition of p38 mitogen-activated protein kinase: dose-dependent suppression of leukocyte and endothelial response after endotoxin challenge in humansJan Willem Fijen, Jaap E Tulleken, Anneke C Muller Kobold, et al.
Experimental Brain Research|August 11, 2016
Implicit motor sequence learning in schizophrenia and in old age: reduced performance only in the third sessionClaudia Cornelis, Livia J De Picker, Peter De Boer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 5, 2017
Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy : A comparison of benefitsPeter de Boer, Agustinus J A J van de Schoot, Henrike Westerveld, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2014
Pharmacology of JNJ-42314415, a centrally active phosphodiesterase 10A (PDE10A) inhibitor: a comparison of PDE10A inhibitors with D2 receptor blockers as potential antipsychotic drugsAnton A H P Megens, Herman M R Hendrickx, Koen A Hens, et al.
Translational Psychiatry|September 5, 2019
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorderKasper Recourt, Peter de Boer, Rob Zuiker, et al.
Translational Psychiatry|October 4, 2019
Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorderKasper Recourt, Peter de Boer, Rob Zuiker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Patterns of care survey: Radiotherapy for women with locally advanced cervical cancerPeter de Boer, Ina M Jürgenliemk-Schulz, Henrike Westerveld, et al.
Cell|July 15, 2006
Resolution of chiasmata in oocytes requires separase-mediated proteolysisNobuaki R Kudo, Katja Wassmann, Martin Anger, et al.
European Radiology|June 27, 2018
Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: a multicentre studyMaarten G Thomeer, Vincent Vandecaveye, Loes Braun, et al.
Pageof 9